AstraZeneca and Lilly to collaborate on Immuno-oncology combination clinical trial in solid tumours
|
29 May 2015 |
AstraZeneca provides update on brodalumab development programme
|
22 May 2015 |
AstraZeneca to invest in new biologics manufacturing facility in Södertälje, Sweden
|
18 May 2015 |
AstraZeneca and Montreal Heart Institute to screen 80,000 samples for cardiovascular and diabetes genetic traits
|
13 May 2015 |
FDA grants Priority Review for potential new indication for Brilinta
|
29 April 2015 |
AstraZeneca and Innate Pharma announce global co-development and commercialisation collaboration for IPH2201 in immuno-oncology
|
24 April 2015 |
AstraZeneca and PatientsLikeMe announce global research collaboration
|
13 April 2015 |
AstraZeneca joins Genomics England consortium
|
27 March 2015 |
AstraZeneca to collaborate with the Harvard Stem Cell Institute in diabetes
|
25 March 2015 |
AstraZeneca announces positive Phase III top-line results for PT003 from PINNACLE 1 and PINNACLE 2 studies in COPD
|
18 March 2015 |